Gel injections, usually containing hyaluronic acid, can reduce pain and improve knee function in people with meniscus tears, but they do not reliably heal the torn tissue itself. Several clinical trials show meaningful pain relief lasting months, and one randomized study even documented shrinkage of the tear on MRI. Yet the broader evidence is mixed, and adding hyaluronic acid on top of surgery or physical therapy has sometimes shown no extra benefit at all. The answer depends heavily on the type of tear, where it sits in the meniscus, and what you’re comparing the injection to.
Why Meniscus Tears Are Stubborn
The meniscus is a crescent-shaped wedge of cartilage that sits between the thighbone and shinbone. It acts as a shock absorber: biomechanical studies confirm that removing meniscal tissue measurably reduces the knee’s ability to cushion both sudden impacts and repetitive loads.1PubMed Central. Knee Joint Menisci Are Shock Absorbers: A Biomechanical In-Vitro Study on Porcine Stifle Joints Lose part of that cushion and you accelerate wear on the joint’s remaining cartilage, which is why doctors try to preserve as much meniscus as possible.
The catch is that meniscal tissue has limited ability to repair itself. The outer rim of the meniscus has a blood supply, and tears in that zone can heal if given the right conditions. Move toward the inner two-thirds, though, and blood flow drops off sharply. Because tissue repair fundamentally depends on blood delivering the cells and nutrients needed for healing, tears in the inner, avascular zone have a much harder time closing on their own.2PubMed Central. Biological strategies to enhance healing of the avascular area of the meniscus This is one reason clinicians have been interested in injections that might either help the tissue repair or at least manage symptoms well enough to avoid surgery.
What Gel Injections Actually Do Inside the Joint
When people say “gel injection” for the knee, they almost always mean viscosupplementation: an injection of hyaluronic acid, the same molecule that naturally gives synovial fluid its thick, slippery texture. Healthy joints are lubricated by synovial fluid rich in hyaluronic acid. In a damaged or arthritic knee, that fluid thins out, and the joint loses some of its natural cushioning and lubrication. The injection is meant to restore that viscosity, essentially topping off the lubricant.3PubMed Central. Rheological properties and clinical efficacy of a chemically modified hyaluronic acid for joint health enhancement
But the effect may go beyond simple lubrication. Lab research shows that hyaluronic acid interacts with cells in the meniscus itself, promoting cell growth and migration while also suppressing a key pathway involved in cell death. In experiments on human meniscus cells, hyaluronic acid treatment reduced programmed cell death triggered by inflammatory signals and boosted the expression of genes involved in producing cartilage-building molecules like type II collagen.4PubMed. Hyaluronic acid promotes proliferation and migration of human meniscus cells via a CD44-dependent mechanism Researchers have also explored hyaluronic acid hydrogels as scaffolds that mimic the structure of meniscal tissue, calm inflammation, and encourage new blood vessel formation, all of which could theoretically support tissue regeneration.5PubMed Central. Advances in hyaluronic acid hydrogel for meniscus repair
These cellular and biomechanical effects are promising in the lab, but the leap from test tube to clinical reality is significant. The question is whether injecting hyaluronic acid into a living knee translates into meaningful healing or just symptom management.
Clinical Evidence for Symptom Relief
A handful of clinical trials have specifically tested hyaluronic acid injections in patients with meniscus tears, as opposed to the more common studies looking at osteoarthritis alone. One randomized controlled trial compared a chemically modified hyaluronic acid formulation (HYADD4) against a control group in patients with documented meniscal lesions. The injection group saw a significant drop in pain scores within two weeks, and that improvement held at every follow-up visit. More strikingly, MRI scans showed a measurable reduction in both the length and depth of the meniscal tear in the injection group compared to controls.6PubMed Central. A new hydrogel for the conservative treatment of meniscal lesions: a randomized controlled study That structural finding is unusual; most injectable treatments for knee problems show symptom changes without clear evidence of physical repair on imaging.
Another study tested three different hyaluronic acid formulations in young and middle-aged patients with early-stage meniscal injuries. All three groups experienced significant reductions in pain scores and improvements in overall knee function at one, three, and six months after injection.7PubMed Central. Therapeutic efficacy of three hyaluronic acid formulations in young and middle-aged patients with early-stage meniscal injuries These results are encouraging, but both studies were relatively small, and neither followed patients beyond six months. The durability of the benefit remains an open question.
When Gel Injections Don’t Add Much
Not every study paints a rosy picture. A randomized clinical trial looked at what happened when hyaluronic acid injections were combined with either arthroscopic surgery or physical therapy for degenerative meniscus tears. The researchers found that adding the injection to either treatment had no effect on pain, knee function, or range of motion compared to surgery or therapy alone.8PubMed. Comparison of physical therapy and arthroscopic partial meniscectomy treatments in degenerative meniscus tears and the effect of combined hyaluronic acid injection with these treatments In other words, the gel injection was essentially redundant when layered on top of established treatments.
This is an important finding because many patients ask about injections as something they can add to whatever they’re already doing. The evidence here suggests that if you’re already committed to a solid physical therapy program or have already had surgery, the hyaluronic acid injection may not provide additional benefit for a degenerative tear. That doesn’t mean it’s useless as a standalone option, but it challenges the idea that stacking treatments always leads to better outcomes.
The distinction between degenerative and traumatic tears matters here. Degenerative tears, common in people over 40, develop gradually as the meniscal tissue weakens with age. Traumatic tears happen from a sudden twist or blow to the knee, often in younger and more active people. The biology and the treatment response can differ, and research that lumps them together can obscure real differences in how well a given injection works for each type.
How Gel Injections Stack Up Against Other Injectables
Hyaluronic acid isn’t the only thing doctors inject into knees with meniscus tears. Corticosteroid injections and platelet-rich plasma (PRP) are the other main options, and each works through a different mechanism. A systematic review covering 24 studies and over 2,000 patients compared these approaches head to head.9Journal of Cartilage & Joint Preservation. Can we treat meniscal tears with injectables? A systematic review of clinical outcomes following platelet-rich plasma, corticosteroid, and other injective therapies for degenerative and traumatic meniscal lesions
Corticosteroids provided short-term symptom relief but showed no structural benefit. They’re the fast-acting option: you feel better quickly, but the relief fades and the tear itself isn’t affected. PRP, which concentrates growth factors from your own blood, demonstrated more consistent improvements in both pain and function, with more than 80% of patients in the reviewed studies avoiding surgery at mid-term follow-up. PRP also showed limited evidence of structural improvement on MRI, though the signal wasn’t strong. Other injectable therapies, including various hyaluronic acid formulations, showed promising early results but were hampered by small sample sizes and inconsistent study designs.
The overall quality of the evidence across all these injectable studies was rated moderate to low. That doesn’t mean the treatments don’t work, but it does mean the research hasn’t yet reached the level where anyone can make definitive claims about which injection is best for which tear. If your doctor recommends one over another, the choice is often based on clinical judgment and what’s available rather than on a clear hierarchy from the data.
What the Tear Location Means for Treatment Choice
The location of a meniscus tear within the tissue is one of the strongest predictors of how well any conservative treatment will perform. The outer third, sometimes called the red zone because of its blood supply, has the best shot at healing. The inner third, the white zone, has almost no blood flow and heals poorly. The transition zone between them falls somewhere in between. Research confirms that this gradient in blood supply directly translates to a gradient in healing capacity.10PubMed Central. Clinical Outcomes of Inside-Out Meniscal Repair According to Anatomic Zone of the Meniscal Tear
For gel injections, this anatomical reality matters more than most patients realize. A tear in the outer zone might respond to injections that reduce inflammation and give the tissue time to close, since the blood supply is already doing most of the repair work. A tear in the inner zone, by contrast, lacks the vascular infrastructure to mount a healing response regardless of what you inject into the joint space. The hyaluronic acid might still reduce pain by improving lubrication and calming inflammation, but expecting actual tissue repair in the avascular zone is asking a lot from any non-surgical treatment.
This is why MRI results are so important before deciding on a treatment plan. Two patients with the same pain level and the same general diagnosis of “meniscus tear” can have very different prognoses depending on where in the meniscus the damage sits.
Safety and Side Effects
Gel injections have a reassuring safety track record. In a large post-marketing study, all reported side effects from hyaluronic acid knee injections were local and temporary, limited to pain, swelling, and redness at the injection site.11PubMed Central. Efficacy and safety of cross-linked hyaluronic acid single injection on osteoarthritis of the knee: a post-marketing Phase IV study Serious reactions are rare. An analysis of nearly 700,000 hyaluronic acid injections found that inflammation or infection within three days of the injection occurred in up to 0.03% of cases, with no significant differences between the major product types.12PubMed Central. Risk of Severe Acute Localized Reactions for Different Intraarticular Hyaluronic Acid Knee Injections in a Real-World Setting
That said, not all hyaluronic acid products are identical. They vary in molecular weight, how they’re manufactured, and whether they’re derived from animal tissue or bacterial fermentation. These differences can affect side-effect profiles. Products derived from bacterial fermentation tend to produce fewer joint effusions (fluid buildup) and fewer acute flare-ups at the injection site compared to those sourced from rooster combs. Higher-molecular-weight products had fewer treatment discontinuations due to adverse events but slightly more injection-site flare-ups.13PubMed. Product Differences in Intra-articular Hyaluronic Acids for Osteoarthritis of the Knee These are minor distinctions for most patients, but if you’ve had a bad reaction to one product, switching to a different formulation might be worth discussing.
The main practical risk isn’t a side effect from the injection itself, but the cost of delay. If a meniscus tear is large, unstable, or causing mechanical symptoms like the knee catching or locking, spending months on injections that ultimately fail means the surrounding cartilage continues to degrade during that window. The meniscus’s shock-absorbing role means that an untreated unstable tear can accelerate damage to the rest of the joint.
The Cost Question
Hyaluronic acid injections aren’t cheap, and insurance coverage varies. A typical course involves one to five injections spaced a week apart, depending on the product, and the out-of-pocket cost can range from a few hundred to over a thousand dollars per course. Whether that’s a good investment depends partly on what you’re comparing it to.
A surveillance study tracking direct treatment costs over 24 months found that patients who started with non-surgical care for medial meniscus deficiency had average costs that were not statistically different from those who started with partial meniscectomy surgery, coming in at roughly $4,000 to $4,500 on average for either path.14Taylor & Francis Online / PubMed Central. Direct treatment cost outcomes among patients with medial meniscus deficiency: results from a 24-month surveillance study The real cost outlier was the small group of non-surgical patients who eventually needed a total knee replacement during the study period, whose average costs soared past $32,000. That’s a small subgroup, but it underscores the point that conservative treatment isn’t always the cheaper option if it delays necessary intervention.
For many patients, the real value of injections is buying time. If a gel injection provides six months of functional improvement and delays or prevents a surgery, that’s a practical win even if the tear itself hasn’t healed. But if you find yourself coming back for repeated injection courses with diminishing returns, the math starts to shift.
Who Is a Good Candidate
The patients most likely to benefit from gel injections for a meniscus tear tend to share some common features. Smaller, stable tears without mechanical symptoms like locking or catching are the sweet spot. Degenerative tears in middle-aged or older adults who also have some early osteoarthritis are a reasonable target, since the injection addresses both the meniscal symptoms and the arthritic joint environment simultaneously. Patients who can’t have surgery for medical reasons or who want to postpone it are also good candidates, provided they understand the injection is managing symptoms rather than curing the tear.
Patients with large, displaced, or bucket-handle tears generally need surgical intervention. These tears can physically block the knee from straightening and cause rapid cartilage damage if left untreated. No injection addresses that mechanical problem. Similarly, young athletes with acute traumatic tears in the outer vascular zone are usually better served by surgical repair, which has high success rates in that population and preserves the meniscus for decades of future use.
Hyaluronic Acid Hydrogels and Future Directions
The next generation of gel-based treatments is moving beyond simple viscosupplementation. Researchers are developing hyaluronic acid hydrogels that act as scaffolds, designed to be injected or implanted directly into the tear site rather than just floating in the joint fluid. These hydrogels can be engineered to carry cells, release growth factors slowly, and mimic the mechanical stiffness of native meniscal tissue.5PubMed Central. Advances in hyaluronic acid hydrogel for meniscus repair The goal is to provide a structural template that guides the body’s own repair processes, especially in the avascular inner zone where healing has historically been considered almost impossible without surgery.
Some early-stage work has combined these hydrogels with mesenchymal stem cells or platelet-derived growth factors, trying to deliver both the scaffold and the biological signals needed to kick-start regeneration. The lab results are encouraging, with studies showing that hyaluronic acid carriers can promote the kinds of cellular behaviors you’d need for tissue repair: migration of repair cells into the damaged area, new matrix production, and dampened inflammation.4PubMed. Hyaluronic acid promotes proliferation and migration of human meniscus cells via a CD44-dependent mechanism But clinical translation is still in its early stages, and most of these advanced hydrogels are years away from being available in your orthopedist’s office.
The broader trend in meniscus treatment is a move away from the old approach of simply cutting out damaged tissue and toward preservation and regeneration. Gel injections, in their current form, represent an early step in that direction. They don’t regenerate meniscal tissue in any dramatic way for most patients, but they can meaningfully improve quality of life, and the science behind them is evolving quickly enough that the injections available five years from now may be substantially more effective than what’s on the market today.